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SUMMARY 
Newcastle disease (ND) is endemic in Nigeria and constitutes a major problem to poultry 
production especially commercial egg production. Despite vaccination of birds, some 
farmers and other stakeholders still believe that there is shortened protection interval 
between vaccinations leading to frequent outbreaks. This work studied the antibody profile 
in vaccinated birds using Newcastle disease vaccine, La Sota (NDVL) with a view to 
establishing the rise and decline in antibody titre after vaccination and thereby 
determining the protection interval in our local environment. Two hundred and eighty 
(280) Shaver brown layers at 78% hen house production were used for the experiment. 
When their antibody levels were at Geometric Mean Titre of 12.1, they were vaccinated 
with NDVL through the oral route. On a monthly basis, the antibody titre was determined 
and 80 birds were taken to a distant location and challenged with a velogenic strain of 
Newcastle disease virus (NDV). Results showed good protection at 4 weeks, fair protection 
at 8 weeks and no protection at 12 weeks post vaccination (PV). We therefore recommend 
that under the Nigerian condition, laying flocks should be revaccinated at 7-8 weeks 
interval with NDVL. 
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Introduction  
Newcastle disease (ND) is an acute, 
contagious viral disease of domestic poultry 
and many other species of birds causing 
high morbidity and mortality (Aini et al., 
1990). It is world wide in distribution and 
the velogenic strain can cause mortalities 
ranging from 80-100% in unvaccinated birds 
(Alexander, 1997). The disease presents 
primarily as a respiratory disease with 
depression, nervous manifestations and 
diarrhea.  The disease is caused by a 
filterable virus known as Newcastle disease 
virus (NDV) which is an RNA virus 
belonging to the genus Rubulavirus and  
 
Family Paramyxoviridae enveloped with 
helical symmetry and negative sense single 
stranded genome (Seal et al., 2000).  
ND is endemic in Nigeria and has been a 
limiting factor to poultry meat and egg 
production (Saidu et al., 1994). Poultry 
production in Nigeria combines the exotic 
types which are mostly reared on 
commercial basis and the local chickens 
which are mostly scavengers. For the 
farmers who produce eggs, common 
experience has shown inconsistent 
production among the layers. Vaccinations 
against ND do not produce protection lasting 
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for a reasonable period. There have been 
reports of frequent outbreaks of sub clinical 
ND in vaccinated birds resulting in reduced 
egg production and accompanying economic 
losses. Sometimes, the condition will not 
show any overt sign but what is noticed is 
reduced egg production, and production of 
eggs with aberrant and discoloured shells. 
Because of this, many farmers and 
professionals have resorted to their own self 
designed schedule of vaccination with 
varying results. This work therefore 
investigated the antibody profile in laying 
birds with the aim of establishing the decline 
and possibly recommends intervals between 
revaccinations.  
 
MATERIALS AND METHODS  
Chicken: A total of 280 shaver brown layers 
were used for the experiment. The birds 
were 48 weeks old and at an average of 78% 
hen house-egg production. They were kept 
under deep litter system with feed and water 
given ad-libitum. The birds were vaccinated 
against ND, Infectious bursal disease and 
Fowl pox during the brooding stages. 
 
Vaccine: Newcastle disease vaccine, La 
Sota (NDVL) was procured from the 
National Veterinary Research Institute 
(NVRI) Vom Plateau State. Before 
administration to the birds, the strength of 
the vaccine was tested using 
Haemagglutination (HA) test by the method 
described by Allan, and Gough (1974). 
 
Vaccine administration: The antibody 
levels in the birds were monitored until it 
was at HI titre of ≤2 (Beard, 1989). A vial of 
the vaccine containing 200 doses was 
reconstituted with 200ml of distilled water. 
Each bird was vaccinated with a single dose 
(1ml) of the vaccine through the oral route 
by drenching.  
 
Antibody determination: The antibody 
responses in the birds were determined at 4, 
8 and 12 weeks post vaccination (PV) using 
H1 test.  
 
Virus Challenge: At 4, 8 and 12 weeks PV, 
80 birds were challenged with a velogenic 
(VGF-1) NDV strain by the intramuscular 
route (Echeonwu et al., 1993). An ampoule 
containing this virus in a freeze-dried state 
was reconstituted with 2ml of distilled 
water. This suspension was further diluted 
with phosphate buffered saline (PBS) at a 
ratio of 1:1000 to give a median embryo 
infective dose (EID50) titre of 10
6.36 
per ml. 
Each bird was challenged with 0.2ml of this 
inoculum. The following parameters were 
monitored 3 days post challenge (PC)-
development of clinical signs; percentage 
egg production; mortalities; and virus 
isolation from cloacal swabs.  
 
Haemagglutination (HA) and 
Heamagglutination Inhibition (HI) Tests 
Two milliliters (2ml) each of ND antibody 
free blood was collected from three adult 
birds in a test tube containing EDTA as 
anticoagulant. The blood was washed in 
phosphate buffered saline (PBS) by 
centrifugation at 3000 rpm for 5 minutes. 
This was repeated until a clear supernant 
was obtained. The packed RBC was re-
suspended in a measured volume of PBS 
solution to make 0.5 per cent RBC 
suspension (Beard, 1989). 
 
Haemagglutination (HA) Test: 
The HA titre of the antigen was determined 
as described by Allan, and Gough (1974) 
and Allan et al., (1978) and diluted to 
contain 4-HA units. This concentration was 









Heamagglutination Inhibition (HI) Test: 
The HI titers of the sera were expressed as 
reciprocal of the last dilution showing no 
agglutination of the RBC (Beard, 1989). The 
GMT was calculated using the Tube number 
method and Table described by Villegas and 
Purchase (1989).  
 
3 Virus Isolation 
Virus isolation was done according to 
procedures outlined by Kalter, (1963). The 
virus was re-isolated in 9-10 day-old 
embryonated specific antibody negative 
(SAN) chicken eggs by inoculation with 0.1 
ml infectious cloacal samples into the 




Antibody profile as determined by HI test 
was very low before vaccination with 
NDVL, high at 4 weeks PV, declined at 8 
weeks PV and became low at 12 weeks PV 
(Table I).  
 
Clinical signs: No clinical sign was 
observed in the birds challenged at 4 weeks 
PV. Those challenged at 8 weeks PV 
showed slight reduction in feed and water 
consumption, slight dullness and mild 
diarrhea. Those challenged at 12 weeks 
showed signs of ND with marked reduction 
in feed and water consumption, greenish 
diarrhea and loss of body condition(Table 
II).  
Average egg production: However, egg 
production dropped from 78% before 
vaccination to 59%  at 4 weeks PV ; 43% at 
8 weeks PV; and 14% at 12 weeks PV.  
 
Mortality: No mortality occurred at 4 
weeks PV; one bird died at 8 weeks PV 
while a total of 21 birds died at 12 weeks 
PV.  
 
Virus isolation: Ten birds each were used 
for this and virus was isolated from the 
cloacal swab of 1 bird at 4 weeks PV, 5 
birds at 8 weeks PV and from all the birds 






Table I: Antibody profile in laying birds as determined by Geometric Mean Titre (GMT) 
before and after vaccination with NDVL.  
 
 Before Vaccination  4 weeks PV 8 weeks PV 12 weeks PV 




















































































 +   = mild signs of NewD signs 
 ++ = classical ND sign  
 
Discussion 
Vaccination in broiler chicks can be 
especially difficult due to the presence of 
maternal antibodies and because of their 
short life such that broiler chickens are not 
vaccinated in countries where there is low 
risk of ND (Alexander 1997). This cannot be 
possible in Nigeria because of the 
endemicity of ND. Vaccination of laying 
birds has always required more than one 
vaccination to maintain immunity 
throughout their lives, and this actually 
depends on the local condition (Allan et al, 
1978). Local custom or circumstances result 
in too little vaccination, over vaccination or 
mistiming of vaccination, all of which may 
have serious consequences. The problem 
affects poultry farmer in tropical developing 
countries and frequently results in what has 
been described as “vaccine abuse” (Higgins 
and Shortridge, 1988).  
The result showed that there was good 
protection at 4 weeks PV, fair protection at 8 
weeks PV and no protection at 12 weeks 
PV. 
Virus isolation from some birds challenged 
before 12 weeks PV agrees with the 
observation of Parede and Young (1990) 
that ND vaccination protects birds from 
more serious consequences of disease; but 
virus replication and shedding may still 
occur although at a reduced level. Moreover, 
Ezema et al., (2008), observed 
histopathological lesions in chickens 3 
weeks after vaccination without overt 
clinical disease, therefore, vaccination 
against ND can protect birds from clinical 
disease but not from development of some 




histopathological lesions and slight 
multiplication of the virus. The development 
of antibody after vaccination of layers 
declines appreciably within a short time in 
ND and this depends on certain conditions 
one of which is the transfer of the 
immunoglobulin in the eggs laid by the 
birds. Estimation of this decline rate within a 
region will be helpful in determining periods 
between revaccinations (Spradbrow, 1999). 
Alexander (1999) listed the different 
parameters that must be considered in 
devising vaccination programme as disease 
situation, disease control policies, presence 
of other organisms, size of flock, expected 
life of the flock, available labour, climatic 
condition, economics of vaccination, type of 
vaccine and past performance of vaccination 
programmes. In Nigeria, ND is endemic 
with the environment being heavily 
contaminated with other infectious agents. 
Therefore frequent vaccination against ND 
is more indicated in laying flock than in non 
laying flock.  
From this work, we recommend that laying 
birds should be vaccinated with NDVL at 7-
8 weeks interval for maximum protection 
against ND.  
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